|
AT280356B
(de)
|
1968-03-06 |
1970-04-10 |
Telefonbau & Normalzeit Gmbh |
Schaltungsanordnung zur Steuerung des zur Zwischenspeicherung des Zeitwertes eines Signales verwendeten Kondensators eines Demodulators einer Zeitmultiplexanlage
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
CH660375A5
(it)
|
1983-02-08 |
1987-04-15 |
Sclavo Spa |
Procedimento per la produzione di proteine correlate alla tossina difterica.
|
|
CA1247080A
(en)
|
1983-03-08 |
1988-12-20 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4650764A
(en)
|
1983-04-12 |
1987-03-17 |
Wisconsin Alumni Research Foundation |
Helper cell
|
|
US4668829A
(en)
*
|
1984-07-18 |
1987-05-26 |
University Patents, Inc. |
Ferroelectric smectic liquid crystals
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
GB8424757D0
(en)
|
1984-10-01 |
1984-11-07 |
Pasteur Institut |
Retroviral vector
|
|
SE8405493D0
(sv)
|
1984-11-01 |
1984-11-01 |
Bror Morein |
Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
|
|
FR2573436B1
(fr)
|
1984-11-20 |
1989-02-17 |
Pasteur Institut |
Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US4666829A
(en)
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
|
WO1987001130A1
(en)
|
1985-08-15 |
1987-02-26 |
Stauffer Chemical Company |
Tryptophan producing microorganism
|
|
US5078996A
(en)
|
1985-08-16 |
1992-01-07 |
Immunex Corporation |
Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
EP0247091B1
(en)
|
1985-11-01 |
1993-09-29 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
US5514581A
(en)
*
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
|
US4980289A
(en)
|
1987-04-27 |
1990-12-25 |
Wisconsin Alumni Research Foundation |
Promoter deficient retroviral vector
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
RU2023448C1
(ru)
|
1987-07-30 |
1994-11-30 |
Сентро Насьональ Де Биопрепарадос |
Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
|
|
JPH01144977A
(ja)
|
1987-11-30 |
1989-06-07 |
Agency Of Ind Science & Technol |
新規組換えプラスミドｐＴＰＧＩＦ２
|
|
CA1315719C
(en)
|
1988-02-05 |
1993-04-06 |
Arthur Bank |
Retroviral packaging cell lines and processes of using same
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
CA1339354C
(en)
|
1988-09-01 |
1997-08-26 |
The Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
|
US7118757B1
(en)
*
|
1988-12-19 |
2006-10-10 |
Wyeth Holdings Corporation |
Meningococcal class 1 outer-membrane protein vaccine
|
|
US5124263A
(en)
|
1989-01-12 |
1992-06-23 |
Wisconsin Alumni Research Foundation |
Recombination resistant retroviral helper cell and products produced thereby
|
|
DE69033600T2
(de)
|
1989-03-09 |
2001-04-05 |
American Cyanamid Co., Madison |
Verfahren zur Isolierung von Haemopnilus influenzae Protein-E
|
|
US5354844A
(en)
|
1989-03-16 |
1994-10-11 |
Boehringer Ingelheim International Gmbh |
Protein-polycation conjugates
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
CA2039921A1
(en)
|
1990-04-16 |
1991-10-17 |
Xandra O. Breakefield |
Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
EP0467714A1
(en)
|
1990-07-19 |
1992-01-22 |
Merck & Co. Inc. |
The class II protein of the outer membrane of neisseria meningitidis
|
|
JPH0453645U
(esLanguage)
*
|
1990-09-12 |
1992-05-07 |
|
|
|
WO1992005263A1
(en)
|
1990-09-25 |
1992-04-02 |
Cantab Pharmaceuticals Research Limited |
Viral defective vaccine produced by transcomplementing cell line
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
IL101715A
(en)
|
1991-05-02 |
2005-06-19 |
Amgen Inc |
Recombinant dna-derived cholera toxin subunit analogs
|
|
WO1993007897A1
(en)
|
1991-10-21 |
1993-04-29 |
Medimmune, Inc. |
Bacterial expression vectors containing dna encoding secretion signals of lipoproteins
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
IT1253009B
(it)
|
1991-12-31 |
1995-07-10 |
Sclavo Ricerca S R L |
Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
|
|
WO1993015115A1
(en)
*
|
1992-01-24 |
1993-08-05 |
Cornell Research Foundation, Inc. |
E. coli dna polymerase iii holoenzyme and subunits
|
|
WO1994012649A2
(en)
|
1992-12-03 |
1994-06-09 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
ES2231770T3
(es)
|
1993-03-05 |
2005-05-16 |
Wyeth Holdings Corporation |
Nuevos plasmidos para la produccion de proteina crm y toxina difterica.
|
|
CA2158148A1
(en)
|
1993-03-19 |
1994-09-29 |
Stephen Charles Inglis |
Defective mutant non-retroviral virus (e.g. hsv) as vaccine
|
|
EP0624376B1
(en)
|
1993-05-13 |
2000-03-15 |
American Cyanamid Company |
Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
AU7264694A
(en)
|
1993-07-13 |
1995-02-13 |
Rhone-Poulenc Rorer S.A. |
Defective adenovirus vectors and use thereof in gene therapy
|
|
US5439808A
(en)
*
|
1993-07-23 |
1995-08-08 |
North American Vaccine, Inc. |
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
|
|
WO1995007358A1
(en)
|
1993-07-30 |
1995-03-16 |
University Of Medicine & Dentistry Of New Jersey |
Efficient gene transfer into primary lymphocytes
|
|
FR2708622B1
(fr)
|
1993-08-02 |
1997-04-18 |
Raymond Hamers |
Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
|
|
US5550213A
(en)
*
|
1993-12-27 |
1996-08-27 |
Rutgers, The State University Of New Jersey |
Inhibitors of urokinase plasminogen activator
|
|
FR2714830B1
(fr)
|
1994-01-10 |
1996-03-22 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
|
FR2715847B1
(fr)
|
1994-02-08 |
1996-04-12 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
|
FI98045C
(fi)
|
1994-02-21 |
1997-04-10 |
Arto Remes |
Laite inkontinenssihoitoa varten
|
|
FR2716459B1
(fr)
|
1994-02-22 |
1996-05-10 |
Univ Paris Curie |
Système hôte-vecteur utilisable en thérapie génique.
|
|
WO1995026411A2
(en)
|
1994-03-25 |
1995-10-05 |
The Uab Research Foundation |
Composition and methods for creating syngeneic recombinant virus-producing cells
|
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
WO1995028494A1
(en)
|
1994-04-15 |
1995-10-26 |
Targeted Genetics Corporation |
Gene delivery fusion proteins
|
|
US5571515A
(en)
|
1994-04-18 |
1996-11-05 |
The Wistar Institute Of Anatomy & Biology |
Compositions and methods for use of IL-12 as an adjuvant
|
|
EP0710118B1
(en)
*
|
1994-04-20 |
1998-11-25 |
U.S. Department Of The Army |
Vaccine against gram-negative bacterial infections
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US5565204A
(en)
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
|
US5837533A
(en)
|
1994-09-28 |
1998-11-17 |
American Home Products Corporation |
Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
|
|
GB9422096D0
(en)
|
1994-11-02 |
1994-12-21 |
Biocine Spa |
Combined meningitis vaccine
|
|
FR2727679B1
(fr)
|
1994-12-05 |
1997-01-03 |
Rhone Poulenc Rorer Sa |
Nouveaux agents de transfection et leurs applications pharmaceutiques
|
|
BE1008978A5
(fr)
|
1994-12-27 |
1996-10-01 |
Solvay |
Adjuvants pour vaccins.
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
WO1996039036A1
(en)
|
1995-06-05 |
1996-12-12 |
The University Of Alabama At Birmingham Research Foundation |
Composition and methods for creating syngeneic recombinant virus-producing cells
|
|
FI974422L
(fi)
*
|
1995-06-07 |
1998-02-04 |
Connaught Lab |
Lipoproteiinien ilmentäminen
|
|
FR2741358B1
(fr)
|
1995-11-17 |
1998-01-02 |
Centre Nat Rech Scient |
Production de vecteurs retroviraux par l'intermediaire de vecteurs viraux a base de virus a adn
|
|
CU22559A1
(es)
*
|
1996-01-17 |
1999-05-03 |
Ct Ingenieria Genetica Biotech |
Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
|
|
US5846547A
(en)
|
1996-01-22 |
1998-12-08 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
US6355255B1
(en)
|
1998-12-07 |
2002-03-12 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
CA2264585C
(en)
|
1996-08-27 |
2005-06-14 |
Chiron Corporation |
Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
|
|
ATE208629T1
(de)
|
1996-08-27 |
2001-11-15 |
Chiron Corp |
Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
|
|
GB9622159D0
(en)
|
1996-10-24 |
1996-12-18 |
Solvay Sociutu Anonyme |
Polyanionic polymers as adjuvants for mucosal immunization
|
|
AU5426098A
(en)
|
1996-10-24 |
1998-05-15 |
Emory University |
Invasion associated genes from (neisseria meningitidis) serogroup
|
|
GB9622660D0
(en)
|
1996-10-31 |
1997-01-08 |
Biocine Spa |
Immunogenic detoxified mutant toxin
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
DE19723095C2
(de)
|
1997-06-02 |
2001-08-23 |
Siemens Ag |
Bildrekonstruktionsverfahren für einen Computertomographen
|
|
ATE290403T1
(de)
|
1997-06-30 |
2005-03-15 |
Roussy Inst Gustave |
Verbesserung der verabreichung der nukleinsäure in zellen der plurizellulären eukaryotischen organismen und kombination zur durchführung des verfahrens
|
|
JP2002507985A
(ja)
|
1997-06-30 |
2002-03-12 |
ローヌ−プーラン・ロレ・エス・アー |
横紋筋に核酸を導入する改良法およびその組合せ
|
|
JP2002515816A
(ja)
|
1997-06-30 |
2002-05-28 |
アバンテイス・フアルマ・エス・アー |
ｉｎ ｖｉｖｏ組織に核酸ベクターを最適に電気導入する装置
|
|
WO1999003501A1
(en)
*
|
1997-07-17 |
1999-01-28 |
North American Vaccine, Inc. |
Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
|
|
JPH1144977A
(ja)
|
1997-07-25 |
1999-02-16 |
Copyer Co Ltd |
画像形成装置
|
|
AU9120898A
(en)
|
1997-08-27 |
1999-03-16 |
Chiron Corporation |
Molecular mimetics of meningococcal b epitopes
|
|
CN1271366A
(zh)
*
|
1997-08-29 |
2000-10-25 |
陶氏化学公司 |
均质填充聚合物复合材料
|
|
ATE476508T1
(de)
|
1997-11-06 |
2010-08-15 |
Novartis Vaccines & Diagnostic |
Neisseriale antigene
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
ES2333071T5
(es)
|
1998-01-14 |
2015-08-17 |
Novartis Vaccines And Diagnostics S.R.L. |
Antígenos de Neisseria meningitidis
|
|
BR9909097A
(pt)
*
|
1998-02-03 |
2000-12-05 |
Ct Disease Contr & Prevention |
Molécula hìbrida de ácido nucleico, vetor de expressão, processos para preparação e para a produção de proteìna psaa lipidada recombinante, proteìna psaa lipidada isolada e purificada produzida recombinantemente, composição imunológica, processos para induzir uma resposta imunológica em um animal e para imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal a um hospedeiro
|
|
GB9806456D0
(en)
|
1998-03-25 |
1998-05-27 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
GB9808734D0
(en)
|
1998-04-23 |
1998-06-24 |
Smithkline Beecham Biolog |
Novel compounds
|
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
|
BR9910089A
(pt)
|
1998-05-01 |
2004-06-08 |
Chiron Corp |
Composições e antìgenos de neisseria meningitidis
|
|
DE69934225T2
(de)
|
1998-05-29 |
2007-09-27 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Kombinierte meningitis b/c impfstoffe
|
|
AU1199900A
(en)
*
|
1998-09-30 |
2000-04-17 |
Walter Reed Army Institute Of Research |
Use of purified invaplex from gram negative bacteria as a vaccine
|
|
ATE378066T1
(de)
|
1998-09-30 |
2007-11-15 |
Wyeth Corp |
Mutiertes cholera holotoxin als hilfsmittel
|
|
JP2004511201A
(ja)
|
1998-10-09 |
2004-04-15 |
カイロン コーポレイション |
ナイセリアゲノム配列およびそれらの使用方法
|
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US6281337B1
(en)
|
1998-11-12 |
2001-08-28 |
Schering Corporation |
Methods for conversion of protein isoforms
|
|
CA2359486A1
(en)
|
1999-01-15 |
2000-07-20 |
Smithkline Beecham Biologicals S.A. |
Neisseria meningitidis polypeptide basb052
|
|
AU2292800A
(en)
|
1999-01-22 |
2000-08-07 |
Smithkline Beecham Biologicals (Sa) |
Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides andprotective antibodies
|
|
GB9902084D0
(en)
|
1999-01-29 |
1999-03-24 |
Smithkline Beecham Biolog |
Novel compounds
|
|
ES2313881T3
(es)
|
1999-02-05 |
2009-03-16 |
MERCK & CO., INC. |
Formulaciones de vacunas frente al papilomavirus humano.
|
|
WO2000050075A2
(en)
|
1999-02-26 |
2000-08-31 |
Chiron S.P.A. |
Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
|
|
US6245568B1
(en)
|
1999-03-26 |
2001-06-12 |
Merck & Co., Inc. |
Human papilloma virus vaccine with disassembled and reassembled virus-like particles
|
|
US7115730B1
(en)
|
1999-04-27 |
2006-10-03 |
Chiron Srl |
Immunogenic detoxified mutant E. coli LT-A-toxin
|
|
WO2000066741A2
(en)
|
1999-04-30 |
2000-11-09 |
Chiron S.P.A. |
Conserved neisserial antigens
|
|
CN1359426A
(zh)
|
1999-04-30 |
2002-07-17 |
希龙公司 |
奈瑟球菌基因组序列及其用法
|
|
ES2563650T3
(es)
*
|
1999-05-19 |
2016-03-15 |
Glaxosmithkline Biologicals Sa |
Composiciones de combinaciones de Neisseria
|
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
|
GB9918319D0
(en)
*
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
US7384640B1
(en)
|
1999-09-30 |
2008-06-10 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant
|
|
EP2275553B1
(en)
|
1999-10-29 |
2015-05-13 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigenic peptides
|
|
BR0015961A
(pt)
|
1999-11-29 |
2003-06-10 |
Chiron Spa |
Antìgeno de neisseria de 85kda
|
|
GB9928196D0
(en)
*
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
JP4948731B2
(ja)
|
1999-12-02 |
2012-06-06 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
凍結乾燥の際に生物学的分子を安定化するための組成物および方法
|
|
PT1248647E
(pt)
*
|
2000-01-17 |
2010-11-18 |
Novartis Vaccines & Diagnostics Srl |
Vacina de vesícula da membrana externa (omv) compreendendo proteínas de membrana externa de n. meningitidis do serogrupo b
|
|
ES2299476T3
(es)
|
2000-02-28 |
2008-06-01 |
Novartis Vaccines And Diagnostics S.R.L. |
Expresion hibrida de proteinas de neisseria.
|
|
RU2293573C2
(ru)
|
2000-06-08 |
2007-02-20 |
Интерселл Аг |
Иммуностимулирующие олигодезоксинуклеотиды
|
|
AT410635B
(de)
|
2000-10-18 |
2003-06-25 |
Cistem Biotechnologies Gmbh |
Vakzin-zusammensetzung
|
|
KR100947757B1
(ko)
|
2001-01-23 |
2010-03-18 |
아벤티스 파스퇴르 |
다가 수막구균 폴리사카라이드―단백질 접합체 백신
|
|
GB0103424D0
(en)
*
|
2001-02-12 |
2001-03-28 |
Chiron Spa |
Gonococcus proteins
|
|
WO2002079246A2
(en)
|
2001-03-30 |
2002-10-10 |
Geneprot, Inc. |
Human arginine-rich protein-related compositions
|
|
AU2002258734A1
(en)
|
2001-04-13 |
2002-10-28 |
Wyeth Holdings Corporation |
Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
|
|
US7534444B2
(en)
|
2001-04-17 |
2009-05-19 |
Novattis Vaccines And Diagnostics, Inc. |
Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
|
|
ATE451386T1
(de)
|
2001-06-07 |
2009-12-15 |
Wyeth Corp |
Mutantenformen von cholera holotoxin als adjuvans
|
|
JP2005508143A
(ja)
|
2001-06-07 |
2005-03-31 |
ワイス・ホールデイングス・コーポレーシヨン |
アジュバントとしてのコレラホロトキシンの突然変異形
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
CA2452720C
(en)
|
2001-07-26 |
2012-04-17 |
Chiron S.R.L. |
Vaccines comprising aluminium adjuvants and histidine
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
CA2460546A1
(en)
|
2001-09-14 |
2003-03-27 |
Invitrogen Corporation |
Dna polymerases and mutants thereof
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
GB0129007D0
(en)
|
2001-12-04 |
2002-01-23 |
Chiron Spa |
Adjuvanted antigenic meningococcal compositions
|
|
EP1490409B1
(en)
|
2002-03-26 |
2008-12-31 |
Novartis Vaccines and Diagnostics S.r.l. |
Modified saccharides having improved stability in water
|
|
GB0302218D0
(en)
|
2003-01-30 |
2003-03-05 |
Chiron Sri |
Vaccine formulation & Mucosal delivery
|
|
WO2003094960A2
(en)
|
2002-05-14 |
2003-11-20 |
Chiron Srl |
Mucosal combination vaccines for bacterial meningitis
|
|
DE60328481D1
(de)
|
2002-05-14 |
2009-09-03 |
Novartis Vaccines & Diagnostic |
Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
GB0220198D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Modified saccharides,conjugates thereof and their manufacture
|
|
EP1549338B1
(en)
|
2002-10-11 |
2010-12-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
|
|
DK2279746T3
(da)
|
2002-11-15 |
2013-11-25 |
Novartis Vaccines & Diagnostic |
Overfladeproteiner i neisseria meningitidis
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
EP1590459A2
(en)
*
|
2003-01-15 |
2005-11-02 |
Wyeth Holdings Corporation |
Methods for increasing neisseria protein expression and compositions thereof
|
|
ES2383175T3
(es)
|
2003-01-30 |
2012-06-18 |
Novartis Ag |
Vacunas inyectables contra múltiples serogrupos de meningococos
|
|
WO2004083251A2
(en)
|
2003-03-17 |
2004-09-30 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
AU2004233012A1
(en)
|
2003-04-16 |
2004-11-04 |
Wyeth Holdings Corporation |
Novel immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
US9107831B2
(en)
|
2003-06-02 |
2015-08-18 |
Novartis Vaccines And Diagonstics, Inc. |
Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens
|
|
US20050019337A1
(en)
|
2003-06-23 |
2005-01-27 |
Ryall Robert P. |
Immunization method against Neisseria meningitidis serogroups A and C
|
|
GB0316560D0
(en)
|
2003-07-15 |
2003-08-20 |
Chiron Srl |
Vesicle filtration
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
PL1670506T3
(pl)
|
2003-10-02 |
2013-04-30 |
Novartis Ag |
Płynne szczepionki przeciw wielu grupom serologicznym meningokoków
|
|
WO2005065708A2
(en)
|
2003-12-30 |
2005-07-21 |
Wyeth |
Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability
|
|
GB0406013D0
(en)
|
2004-03-17 |
2004-04-21 |
Chiron Srl |
Analysis of saccharide vaccines without interference
|
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
GB0408978D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Meningococcal fermentation for preparing conjugate vaccines
|
|
WO2005105140A2
(en)
|
2004-04-30 |
2005-11-10 |
Chiron Srl |
Meningococcal conjugate vaccination
|
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
|
GB0500787D0
(en)
|
2005-01-14 |
2005-02-23 |
Chiron Srl |
Integration of meningococcal conjugate vaccination
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
GB0411387D0
(en)
|
2004-05-21 |
2004-06-23 |
Chiron Srl |
Analysis of saccharide length
|
|
GB0413868D0
(en)
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
|
WO2006011060A2
(en)
|
2004-07-23 |
2006-02-02 |
Chiron Srl |
Polypeptides for oligomeric assembly of antigens
|
|
GB0419408D0
(en)
|
2004-09-01 |
2004-10-06 |
Chiron Srl |
741 chimeric polypeptides
|
|
GB0419846D0
(en)
|
2004-09-07 |
2004-10-13 |
Chiron Srl |
Vaccine adjuvants for saccharides
|
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
CN101107007B
(zh)
|
2005-01-27 |
2011-08-17 |
奥克兰儿童医院及研究中心 |
对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗
|
|
EP1855595A2
(en)
|
2005-03-07 |
2007-11-21 |
ID Biomedical Corporation of Quebec c.o.b. as Glaxosmithkline Biologicals North America |
Pharmaceutical liposomal compositions
|
|
NZ563940A
(en)
|
2005-05-06 |
2010-11-26 |
Novartis Vaccines & Diagnostic |
Immunogens for meningitidis-A vaccines comprising oligosaccharides linked by a phosphonate
|
|
BRPI0612655B1
(pt)
|
2005-06-27 |
2021-06-15 |
Pfizer Ireland Pharmaceuticals |
Composição imunogênica
|
|
AU2006286228A1
(en)
|
2005-09-01 |
2007-03-08 |
Novartis Vaccines And Diagnostics Gmbh & Co Kg |
Multiple vaccination including serogroup C meningococcus
|
|
ES2522521T3
(es)
|
2005-09-05 |
2014-11-14 |
Glaxosmithkline Biologicals Sa |
Ensayo bactericida del suero para antisueros específicos de N. meningitidis
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
EA200801368A1
(ru)
|
2005-12-23 |
2008-12-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Конъюгатные вакцины
|
|
PL2004225T3
(pl)
|
2006-03-22 |
2012-09-28 |
Novartis Ag |
Schematy immunizacji koniugatami meningokokowymi
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
WO2007127668A2
(en)
|
2006-04-26 |
2007-11-08 |
Wyeth |
Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
|
|
US20090123499A1
(en)
|
2006-06-12 |
2009-05-14 |
Nathalie Devos |
Vaccine
|
|
GB0612854D0
(en)
|
2006-06-28 |
2006-08-09 |
Novartis Ag |
Saccharide analysis
|
|
MX2008016280A
(es)
|
2006-06-29 |
2009-03-26 |
Novartis Ag |
Polipeptidos a partir de neisseria meningitidis.
|
|
AU2007277081B2
(en)
|
2006-07-27 |
2014-02-06 |
Wyeth Llc |
High-cell density fed-batch fermentation process for producing recombinant protein
|
|
AR064642A1
(es)
*
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
AU2008259423A1
(en)
|
2007-06-04 |
2008-12-11 |
Novartis Ag |
Formulation of meningitis vaccines
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
EP2185576A4
(en)
*
|
2007-08-02 |
2011-01-12 |
Childrens Hosp & Res Ct Oak |
FHBP- AND LPXL1-BASED VESICIUM VACCINES FOR BROADBAND PROTECTION AGAINST NEISSERIA MENINGITIDIS-RELATED DISEASES
|
|
BR122016015627A2
(pt)
|
2007-10-19 |
2018-10-30 |
Novartis Ag |
kit, composição antigênica liofilizada e método para preparação de uma composição imunogênica
|
|
CA2716212A1
(en)
|
2008-02-21 |
2009-08-27 |
Novartis Ag |
Meningococcal fhbp polypeptides
|
|
JP5689687B2
(ja)
|
2008-03-05 |
2015-03-25 |
サノフィ・パスツールＳａｎｏｆｉｐａｓｔｅｕｒ |
アジュバント含有ワクチン組成物の安定化方法
|
|
EP2631245A1
(en)
|
2008-03-10 |
2013-08-28 |
Children's Hospital & Research Center at Oakland |
Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
|
|
WO2009143168A2
(en)
|
2008-05-19 |
2009-11-26 |
Novartis Ag |
Vaccine assays
|
|
AU2009262893B2
(en)
|
2008-05-30 |
2015-05-21 |
The U.S.A., as represented by The Secretary of the Army, on behalf of Walter Reed Army Institute Of Research |
Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
|
|
EP2326726A4
(en)
|
2008-08-27 |
2011-09-28 |
Childrens Hosp & Res Ct Oak |
FACTOR-BASED H-FACTOR ASSAYS TO DETERMINE BACTERICIDE SERIAL ACTIVITY AGAINST NEISSERIA MENINGITIDIS
|
|
US8470340B2
(en)
|
2008-09-03 |
2013-06-25 |
Children's Hospital & Research Center Oakland |
Peptides presenting an epitope of a domain of factor H binding protein and methods of use
|
|
IT1394288B1
(it)
|
2008-09-12 |
2012-06-06 |
Novartis Vaccines & Diagnostic |
Immunogeni di proteine che legano il fattore h.
|
|
AR073997A1
(es)
|
2008-10-29 |
2010-12-15 |
Wyeth Corp |
Formulaciones de moleculas de union a antigeno de dominio unico. metodo. kit
|
|
GB0822634D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Meningitis vaccines
|
|
JP5410084B2
(ja)
*
|
2008-12-15 |
2014-02-05 |
川上産業株式会社 |
梱包箱及び箱状芯材
|
|
WO2010070453A2
(en)
|
2008-12-17 |
2010-06-24 |
Novartis Ag |
Meningococcal vaccines including hemoglobin receptor
|
|
NZ595234A
(en)
|
2009-03-24 |
2013-12-20 |
Novartis Ag |
Adjuvanting meningococcal factor h binding protein
|
|
CN102438649A
(zh)
|
2009-03-24 |
2012-05-02 |
诺华有限公司 |
脑膜炎球菌h因子结合蛋白和肺炎球菌结合糖的组合物
|
|
MX2011011512A
(es)
|
2009-04-30 |
2012-02-13 |
Novartis Vaccines & Diagnostic |
Proteinas de union de factor h quimericas (fhbp) y metodos de uso.
|
|
US9365885B2
(en)
|
2009-06-16 |
2016-06-14 |
Puiying Annie Mak |
High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
|
|
EP3017828A1
(en)
|
2009-08-27 |
2016-05-11 |
GlaxoSmithKline Biologicals SA |
Hybrid polypeptides including meningococcal fhbp sequences
|
|
IT1395574B1
(it)
|
2009-09-14 |
2012-10-16 |
Guala Dispensing Spa |
Dispositivo di erogazione
|
|
EP2483390A2
(en)
|
2009-09-30 |
2012-08-08 |
Novartis AG |
Expression of meningococcal fhbp polypeptides
|
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
|
JP3158225U
(ja)
*
|
2009-10-22 |
2010-03-25 |
王 文燦 |
折畳める物置袋
|
|
CN102917730A
(zh)
|
2009-10-27 |
2013-02-06 |
诺华有限公司 |
修饰的脑膜炎球菌fHBP多肽
|
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
|
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
US20130004530A1
(en)
|
2010-03-10 |
2013-01-03 |
Jan Poolman |
Vaccine composition
|
|
WO2012020326A1
(en)
|
2010-03-18 |
2012-02-16 |
Novartis Ag |
Adjuvanted vaccines for serogroup b meningococcus
|
|
EP3327028B1
(en)
|
2010-03-30 |
2022-03-16 |
Children's Hospital & Research Center at Oakland |
Factor h binding proteins (fhbp) with altered properties and methods of use thereof
|
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
ES2994878T3
(en)
|
2010-08-23 |
2025-02-03 |
Wyeth Llc |
Stable formulations of neisseria meningitidis rlp2086 antigens
|
|
ES2744471T3
(es)
|
2010-09-04 |
2020-02-25 |
Glaxosmithkline Biologicals Sa |
Ensayos de anticuerpos bactericidas para evaluar la inmunogenia y la potencia de vacunas de sacárido capsular meningocócico
|
|
KR101584871B1
(ko)
|
2010-09-10 |
2016-01-22 |
와이어쓰 엘엘씨 |
네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체
|
|
AU2011300418B2
(en)
|
2010-09-10 |
2016-05-12 |
Glaxosmithkline Biologicals Sa |
Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom
|
|
US20120070457A1
(en)
|
2010-09-10 |
2012-03-22 |
J. Craig Venter Institute, Inc. |
Polypeptides from neisseria meningitidis
|
|
GB201015132D0
(en)
|
2010-09-10 |
2010-10-27 |
Univ Bristol |
Vaccine composition
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
CA2828844C
(en)
|
2011-03-02 |
2020-07-14 |
Novartis Ag |
Combination vaccines with lower doses of antigen and/or adjuvant
|
|
WO2012134975A1
(en)
|
2011-03-28 |
2012-10-04 |
St. Jude Children's Research Hospital |
Methods and compositions employing immunogenic fusion proteins
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
BR122016004924A2
(pt)
|
2012-03-09 |
2019-07-30 |
Pfizer Inc. |
Polipeptídeo isolado e composições imunogênicas compreendendo os mesmos
|
|
EP2964665B1
(en)
|
2013-03-08 |
2018-08-01 |
Pfizer Inc |
Immunogenic fusion polypeptides
|
|
US9965924B2
(en)
|
2013-07-15 |
2018-05-08 |
Ahmnon D. Moskowitz |
Methods, systems, and apparatus for playing multi-zone 21
|
|
CA2923129C
(en)
|
2013-09-08 |
2020-06-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
WO2016132294A1
(en)
|
2015-02-19 |
2016-08-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
US10183070B2
(en)
|
2017-01-31 |
2019-01-22 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|